Literature DB >> 498462

The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies.

E N Prystowsky, E L Pritchett, A D Roses, J Gallagher.   

Abstract

To evaluate the progression of conduction system disease in myotonic muscular dystrophy, nine patients underwent serial electrophysiologic studies at a mean of 35 months apart. At the initial study, seven patients had first-degree atrioventricular block and three of these seven had disease in the His-Purkinje system (HV greater than 55 msec). At the second study, seven patients had prolonged HV intervals, and during the almost 3-year period, HV intervals increased by at least 5 msec in all seven patients. No electrophysiologic or electrocardiographic measures could be found that correlated with progression of conduction disease in these patients. Because of the failure of electrophysiologic measures to predict progression of conduction disease in these patients, electrophysiologic studies are recommended only for symptomatic patients. If significant disease is found in either impulse formation or conduction, permanent pacemaker therapy is warranted.

Entities:  

Mesh:

Year:  1979        PMID: 498462     DOI: 10.1161/01.cir.60.6.1360

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods?

Authors:  D Babuty; L Fauchier; D Tena-Carbi; P Poret; J Leche; M Raynaud; J P Fauchier; P Cosnay
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; J Gehrmann; S Reddy
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 3.  Electrocardiographic abnormalities in patients with myotonic dystrophy.

Authors:  R C Florek; D W Triffon; D E Mann; S P Ringel; M J Reiter
Journal:  West J Med       Date:  1990-07

4.  Electrocardiographic findings in myotonic dystrophy.

Authors:  B O Olofsson; H Forsberg; S Andersson; P Bjerle; A Henriksson; I Wedin
Journal:  Br Heart J       Date:  1988-01

Review 5.  Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

Authors:  David Verhaert; Kathryn Richards; Jill A Rafael-Fortney; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2011-01       Impact factor: 7.792

6.  DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; M J Aronovitz; J Greenwood; C Miller; J Gehrmann; D Housman; M E Mendelsohn; S Reddy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

7.  Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.

Authors:  Bradley A Hardin; Miriam R Lowe; Deepak Bhakta; William J Groh
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

8.  Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.

Authors:  F Rinaldi; A Botta; L Vallo; G Contino; A Morgante; R Iraci; C Catalli; G Silvestri; V M Ventriglia; L Politano; G Novelli
Journal:  Acta Myol       Date:  2008-12

Review 9.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Acute Rheumatic Carditis: A Rare Cause for Reversible Complete Heart Block.

Authors:  Omar A Abdul Ghani; David Singh
Journal:  Hawaii J Med Public Health       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.